China National Medicines Corporation Ltd(600511)
Opinions of the nomination committee of the board of directors on the nomination of director candidates
In accordance with the relevant provisions of the standards for the governance of listed companies, the articles of association and the detailed rules for the implementation of the nomination committee of China National Medicines Corporation Ltd(600511) board of directors, China National Medicines Corporation Ltd(600511) the nomination committee of the seventh board of directors carefully reviewed the relevant materials of the candidates of China National Medicines Corporation Ltd(600511) eighth board of directors, and investigated the relevant departments and personnel of the company on relevant issues, It is considered that the qualifications of each director candidate meet the conditions for serving as a non independent director and independent director of a listed company, and there is no situation that they are not allowed to serve as a director of the company as stipulated in the company law, or that they are determined by the CSRC to be prohibited from entering the market and the prohibition has not been lifted.
The nomination committee of the board of directors nominated Mr. Jiang Xiuchang, Mr. Liu Yong, Mr. Lian Wanyong, Ms. Li Xiaojuan, Mr. Wen Deyong, Ms. Jiang Xin and Mr. Tian Guotao as candidates for non independent directors of the China National Medicines Corporation Ltd(600511) eighth board of directors; Nominate Mr. Yu Xingxi, Mr. Shi Luwen, Mr. Chen Mingyu and Mr. Liu Shen as candidates for independent directors of China National Medicines Corporation Ltd(600511) the eighth board of directors China National Medicines Corporation Ltd(600511) March 16, 2022 signature page of nomination opinions of the nomination committee of the board of directors on the nomination of director candidates members of the nomination committee of the board of directors:
Sheng leiming, Ren Peng, Liu Fengzhen
Liu Yong Lian Wan Yong
China National Medicines Corporation Ltd(600511) March 16, 2022
